Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Chubb
Baxter
Express Scripts
QuintilesIMS
Johnson and Johnson
Healthtrust
Federal Trade Commission
Teva

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202016

« Back to Dashboard

NDA 202016 describes MELAMISA, which is a drug marketed by Novast Labs Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the MELAMISA profile page.

The generic ingredient in MELAMISA is drospirenone; ethinyl estradiol. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the drospirenone; ethinyl estradiol profile page.
Summary for 202016
Tradename:MELAMISA
Applicant:Novast Labs Ltd
Ingredient:drospirenone; ethinyl estradiol
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 202016
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MELAMISA drospirenone; ethinyl estradiol TABLET;ORAL 202016 ANDA Nivagen Pharmaceuticals, Inc. 75834-116 N 75834-116-84
MELAMISA drospirenone; ethinyl estradiol TABLET;ORAL 202016 ANDA Nivagen Pharmaceuticals, Inc. 75834-116 N 75834-116-29

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength3MG;0.02MG
Approval Date:Jan 26, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cerilliant
Boehringer Ingelheim
Queensland Health
Healthtrust
Moodys
Merck
Teva
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot